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BACKGROUND AND PURPOSE: In the search for a diagnostic marker in ALS, we focused our attention
on the hyperintense signal intensity in T1 MTC MR images along the CST, detected in some patients
and not found in other patients with ALS and in control subjects. The aim of this study was to
investigate the relationship between the hyperintense signal intensity in T1 MTC images and white
matter damage. To this purpose, we studied potential heterogeneities in DTI values within our patients
by using TBSS without a priori anatomic information.
MATERIALS AND METHODS: In 43 patients with ALS and 43 healthy control subjects, the presence or
absence of T1MTC hyperintense signal intensity was evaluated.With a DTI analysis with a TBSS approach,
differences in FA distribution between the 2 groups (patients with T1 MTC hyperintense signal intensity
and patients without it) compared with each other and with control subjects were investigated.
RESULTS: We found regional differences in white matter FA between patients with T1 MTC hyper-
intense signal intensity (37.2%) and patients without it. Patients with T1 MTC abnormal signal intensity
showed lower FA strictly limited to the motor network and the posterior aspect of the body of the CC
without extramotor FA reductions, whereas patients without this sign showed FA reductions in several
confluent regions within and outside the CST and in the whole CC.
CONCLUSIONS: T1 MTC hyperintense signal intensity in the CST and posterior CC, when present, is
specific for ALS and represents, among patients with ALS, a possible distinct phenotype of presen-
tation of the disease with prominent UMN involvement.
ABBREVIATIONS: ALS  amyotrophic lateral sclerosis; CC  corpus callosum; CST  corticospinal
tract; FA  fractional anisotropy; FMRIB  Functional MR Imaging of the Brain; FSL  FMRIB
Software Library; LMN  lower motor neuron; MNI  Montreal Neurological Institute; MT 
magnetization transfer; MTC  magnetization transfer contrast; MTR  magnetization transfer
ratio; PD proton attenuation; PLS primary lateral sclerosis; SE spin-echo; TBSS tract-based
spatial statistics; UMN  upper motor neuron
ALS is a chronic neurodegenerative disease that selectivelyinvolves the motor system. Clinically, patients present
with UMN and LMN signs and symptoms. Degeneration of
the UMNs in the precentral gyrus of the cerebral cortex is the
main pathologic change, accompanied by degeneration of the
CST from the cerebral cortex to the spinal cord.1,2
The incidence of sporadic ALS ranges between 1.5 and 2.7
per 100,000 population/year (average 1.89 per 100,000/year)
in Europe and North America.3-7
In patients with ALS, MR imaging of the brain may show
signal-intensity abnormalities, namely a hyperintense signal
intensity in PD-T28-10 and FLAIR11-14 MR images in the CST
from the white matter of the precentral gyrus through the
corona radiata and posterior limbof the internal capsule down
to the brain stem, consistent with CST degeneration.
In addition, a hypointense rim in the posterior aspect of the
precentral gyrus attributed to iron accumulation has been
found.12,13,15-17
Only a few authors have specifically studied T113,16,18 and
T1MTC sequences, finding either a hyperintense signal inten-
sity18 or a reduction ofMTR along the CST,19,20 suggesting the
presence of a more severe tissue damage. MTC imaging fo-
cuses on fundamental relaxation properties of water protons
and is applied to augment image contrast and tissue specific-
ity. This technique is based on the application of off-resonance
radio frequency pulses before the pulse sequence to preferen-
tially saturate immobile protons of macromolecules, which
then transfer magnetization to mobile protons in free water
and can be used to detect changes in the structural status of the
brain tissue.21
MT imaging of the gray matter of patients with ALS re-
cently showed a reduction ofMTR in the precentral gyrus and
also in the prefrontal and temporal cortices.22
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In our experience, T1MTChyperintense signal intensity of
the CST is a characteristic but inconstant finding in patients
with ALS. On the hypothesis that this feature could corre-
spond to a specific disease phenotype, we usedMT imaging of
the white matter of patients with ALS, focusing our attention
on the T1 MTC signal intensity along the CST. To further
characterize the relationship between the hyperintense signal
intensity in T1 MTC and the white matter damage, we fol-
lowed a DTI approach. Among in vivo neuroimaging tech-
niques, DTI is in fact the criterion standard method to assess
the structural integrity of white matter. Diffusion anisotropy
describes how variable the diffusion is in different directions
and is most commonly quantified via a measure known as
FA.23,24 A decrease in FA has been shown to be related to
axonal fiber degeneration and myelin breakdown.25
In this article, we used TBSS,26 a voxel-based approach that
uses extracted and skeletonized white matter tracts in the FA
images of all subjects. TBSS is used in an effort to overcome the
problems associated with the use of standard registration al-
gorithms in other voxel-based approaches.
Several DTI studies have reported reduced FA in the CSTs
of patients with ALS, though the extent and distribution of
these changes have been variable.26-39 Reduced FA along the
CST from the corona radiata through the internal capsule and
into the brain stem has been reported by using both region-
of-interest27,32,36 and voxel-based approaches.28,33,35,38,40
In addition, some authors28,35 described a decrease in FA,
not only in the CST but also in regions outside themainmotor
cortices and the CST. In previous studies that used TBSS, FA
reductions were found in regions outside the motor network,
such as theCC and thewhitematter underneath the premotor,
primary sensory, frontal, and prefrontal cortices.37,38 In an-
other DTI study by using TBSS, the authors reported FA re-
ductions in the body and genu of the CC and corona radiata in
patients with ALS comparedwith controls, andmean diffusiv-
ity, axial diffusivity, and radial diffusivity increased in regions
outside strictly motor areas.39
The aimof our investigationwas to explore the relationship
between the hyperintense signal intensity in T1 MTC and
white matter damage in a series of patients with ALS by using
a TBSS approach and to establish whether there were regional
differences in white matter FA between patients with T1MTC
hyperintense signal intensity and patients without it.
Materials and Methods
Patients
Between February 2010 and January 2011, 43 patients with ALS (26
men, 17 women) with probable or definite ALS as defined by the El
Escorial criteria41 were studied. The mean age of these patients was
63.0 11.2 years; range, 33–79 years; themean ALS functional rating
scale was 40.7 5.0; range, 21–48. The mean time from symptom
onset to the time of scanning (disease duration) was 14.24  7.7
months; range, 3–33 months. Their mean rate of disease progression
was 1.06 U/month. Symptom-onset region was the bulbar segment in
16 and spinal in the other 27 patients. Thirteen patients had prevalent
UMN ALS, 7 had prevalent LMN ALS, and the remaining 23 did not
demonstrate any prevalence of UMN or LMN symptoms.42 Patients
were included in the study if they had no history of other neurologic
and/or vascular diseases. For comparison, 43 sex- and age-matched
healthy controls (mean age, 59.7 14.9 years) were also studied. All
subjects gave informed, written consent before the study, which was
approved by the local research ethics committees.
MR Imaging Acquisition
All subjects were imaged on a Signa HDxt EchoSpeed 1.5T scanner
(GE Healthcare, Milwaukee, Wisconsin) with a maximum gradient
strength of 33 mT/m, maximum slew rate of 120 T/m/s, and an
8-channel phased array head coil. In all patients, sagittal and axial T1
imaging (TR, 500 ms; TE, 14 ms) and sagittal and axial T1 imaging
with MTC (TR, 480 ms; TE, minimum full; MT pulse, 1200 Hz; off-
resonance, 1) was performed. In addition with an SE technique, axial
PD T2-weighted (TR, 2860 ms; TE, 1, minimum full; TE, 2 120 ms)
and coronal FLAIR images (TR, 8000 ms; TE, 80 ms; TI, 2000 ms)
were obtained. Regarding all the sequences detailed above, other im-
aging parameters included a 24-cm FOV, 5-mm section thickness, 1
mm of spacing, and a 224 256 matrix.
We acquired a DTI SE EPI sequence (diffusion-weighted single-
shot SE echo-planar imaging) with a data-acquisition matrix of 96
96; FOV, 240 240 mm; TR, 12,000 ms; TE, minimum full; NEX, 1;
parallel imaging factor, 2; 46 contiguous axial sections; section thick-
ness, 2.5 mm; spacing, 0; 2.5-mm isotropic voxels covering the entire
brain and the brain stem. A pair of diffusion gradients was applied
along 25 noncollinear directions with a b-value of 1000 s/mm2. The
resulting scanning time was 5 minutes, 24 seconds.
A 3D magnetization-prepared rapid acquisition of gradient echo
sequence (preparation time, 600 ms; acquisition matrix, 240  240;
FOV, 240 240 mm; 140 one-millimeter thickness partitions cover-
ing the whole brain and brain stem with a resulting isotropic voxel of
1 mm; parallel imaging factor, 2; scan duration, 2 minutes, 52 sec-
onds) was consequently acquired.
MR Imaging Analysis
T1MTC. In eachMR imaging examination, signal-intensity alter-
ations along theCST andposterior body of theCCwere identified and
scored as absent (0) or present. (1) This was done separately for the
subcortical precentral gyrus, the centrum semiovale, the posterior
aspect of the CC, and the posterior limb of the internal capsule. All
images were evaluated and reviewed by 2 experienced neuroradiolo-
gists blinded to the results and neurologic diagnosis (patients with
ALS versus controls).
DTIProcessing andTBSS.The diffusion tensorwas calculated on
a voxel-by-voxel basis.23 Before running TBSS, we corrected the DTI
acquisition for eddy currents and head-motion distortions (by using
the FSL program Eddy Correct, http://www.fmrib.ox.ac.uk/fsl), and
FA maps were obtained by using the Frequent Domain Transform
Toolbox in FSL.43,44 Then a voxelwise statistical analysis of the FA
maps by usingTBSSwas performed as described in detail in a previous
article.26 The main steps of the analysis were as follows:
Alignmentof FA Images toStandardSpace.Each individual FA im-
age was aligned into 1 1 1mmMNI 152 standard space in 3 steps:
1) By identifying a single subject FA “target” image, towhich every
FA image was nonlinearly aligned
2) By aligning the target image to the MNI 152 standard space by
using affine transformation, and
3) By transforming each individual FA image into the MNI 152
standard space by using both the nonlinear and affine transforma-
tions estimated in the previous steps.45
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Creating the Mean FA Image and Its Skeleton
The transformed individual FA images were averaged to create a
mean FA image. This mean image was then “thinned” to create an FA
skeleton, which represents the tracts that are “common” to all sub-
jects. Finally, this FA skeletonwas thresholded (by using the voxelwise
mean FA across subjects) to discard areas in which a good tract cor-
respondence between subjects was not achieved and to exclude all
voxels that are primarily graymatter or CSF inmost subjects. The aim
of this thresholdingwas to define the set of voxels to be included in the
voxelwise cross-subject statistics. The threshold that we used was
FA 0.2.
Projecting Individual FAMaps onto the Skeleton.Each subject’s
aligned FA image was, in turn, projected onto the mean FA skeleton,
by using the maximum FA value in a search perpendicular to the
skeleton. This step resulted in a 4D image (“skeletonized”), which has
the subject as a fourth dimension; this image was then used in the
voxel-based statistics across subjects.37
Statistical Analysis
We investigated differences in FA between the 2 groups by using a
2-sample t test. We estimated 2 contrasts: a group greater than the
other and vice versa. The resultant statistical maps were thresholded
at P .05, corrected at the cluster level for multiple comparisons by
using a permutation-based approach.46We tested the hypothesis that
there were significant differences in FA: 1) between patients with T1
MTC hyperintense signal intensity along the CST and patients with-
out it; 2) between patients with T1MTC hyperintense signal intensity
and healthy controls; 3) between patients without T1 MTC hyperin-
tense signal intensity and controls.
The mean FA values of the CST and CC were extracted for each
subject by using an atlas-based mask for the regions of interest devel-
oped at the JohnsHopkins University (JHU-ICBM, Baltimore,Mary-
land).47 TheCSTwas evaluated entirely and from the precentral gyrus
to the internal capsule; the CC was evaluated entirely and divided in
the genu, body, and splenium; and the body was divided in the ante-
rior body and posterior body. For the white matter outside the CST
(frontal white matter, parietal white matter, temporal white matter),
the mean FA was also calculated on the basis of regions of interest
derived from MNI templates.
For bilateral regions, the value of FA from the left and right side
was averaged. Before averaging bilateral regions, unilateral measure-
ments were achieved and no differences were found.
Results
T1 MTC Results
The hyperintense signal intensity in T1 MTC in our patients
with ALS was present in 37.2% (16/43) of patients and was
absent in 62.7% (27/43) (Table 1 and Fig 1). This signal inten-
sity was absent in control subjects. Thus, T1MTChyperinten-
sity in our patients with ALS had a low sensitivity, with a neg-
ative predictive value of 0.61, and a high specificity, with a
positive predictive value of 1.
Difference in FA between Patients with T1 MTC
Hyperintense Signal Intensity along the CST and Patients
without It
Patients with T1 MTC hyperintense signal intensity along the
CST had significantly lower FA (all P values.01) compared
with patients without T1MTChyperintensity (Table 2 and Fig
2). In particular, lower FA was found bilaterally from the sub-
cortical precentral gyrus passing through the centrum semi-
ovale, the posterior limb of the internal capsule, the pons, and
middle cerebellar peduncle. Regarding the CC, patients with
T1 MTC hyperintense signal intensity along the CST com-
pared with patients without it showed a significantly lower FA
only in the posterior aspect of the body of the CC (T1 MTC
hyperintense mean FA 0.528  0.015 versus T1 MTC absent
mean FA 0.536  0.015), whereas they showed higher FA in
the entire CC, in the splenium, in the genu, and in the anterior
body (mean FA in the entire CC T1 MTC hyperintense,
0.580  0.018, versus T1 MTC absent mean FA, 0.569 
0.018). Most interesting, in the regions outside the CST (the
white matter adjacent to the superior and middle frontal
gyrus, the parietal and temporal white matter, the anterior
limbs of internal capsule, and the external capsule), the pa-
tients with T1MTC high signal intensity showed increased FA
(mean FA in the frontal white matter, 0.2430.014; mean FA
in the temporal white matter, 0.268 0.013; mean FA in the
parietal white matter, 0.236  0.016) compared with the
group of patients without T1 MTC hyperintense signal inten-
sity (mean FA frontal whitematter, 0.234 0.013;mean FA in
the temporal white matter, 0.245  0.012; mean FA in the
parietal white matter, 0.2120.015).
Difference in FA between Patients with ALS with T1
MTC Hyperintense Signal Intensity and Controls
Patients with ALS with and without T1 MTC hyperintense
signal intensity along the CST had significantly lower FA (all
P values.05) in several confluent regions within and outside
the CST compared with healthy controls. These results are
consistent with previous DTI studies.28,35 In particular, lower
FAwas found bilaterally in the pons,middle cerebellar pedun-
cle, posterior limb of the internal capsule, the centrum semi-
ovale, and subcortical precentral gyrus. Patients also showed a
significantly lower FA throughout the white matter of both
hemispheres, in particular underneath the premotor, primary
sensory, frontal, and prefrontal cortices, adjacent to the supe-
rior andmiddle frontal gyri, in the parietal and temporal white
matter, and in the anterior limbs of the internal and the exter-
nal capsules. Amarked reduction of FAwas found throughout
the entire CC.
Difference in FA between Patients with ALS without T1
MTC Hyperintense Signal Intensity and Controls
The results were comparable with those previously obtained
between patients with T1 MTC hyperintense signal intensity
and healthy controls.
Table 1: Sensitivity and specificity of T1 MTC hyperintense signal
in patients with ALS and controls
Patients with ALS Controls
T1 MTC hyperintensity
Present 16 0
Absent 27 43
Sensitivity (%) 37.2
Specificity (%) 100
Positive predictive value 1
Negative predictive value 0.61
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Correlations between the Presence of T1 MTC
Hyperintense Signal Intensity and the Prevalence of UMN
or LMN Symptoms
A further post hoc investigation of a correlation between the
presence of T1 MTC hyperintense and clinical presentation
showed that 8 of our patients with T1 MTC had clinical fea-
tures of UMN dysfunction; 1 had clinical features of LMN
dysfunction and the remaining 7 did not demonstrate any
prevalence of UMN or LMN symptoms.
Correlations between the Presence of T1 MTC
Hyperintense Signal Intensity and ALS Functional Rating
Scale and Disease Duration
No significant correlation was found between the T1 MTC
hyperintense signal intensity and ALS Functional Rating Scale
and disease duration.
Discussion
An abnormal signal intensity along the CST on T113,16,18 and
T1 MTC sequences,18-20 implying the presence of tissue dam-
age, has been described. High signal intensity in T1 MTC im-
ages along theCST andposterior aspect of theCCwas found in
16 of our 43 patients with ALS and in none of the control
subjects, with a specificity of 100% but a low sensitivity
(37.2%). MTC sequences reflect the structural variations
within a tissue, and in several diseases, MTC images may in-
dicate the presence of structural changes in the tissue, such as
edema and demyelination. The cause of the high signal inten-
sity on T1 MTC images along the CST is unknown; some au-
thors have suggested that the pathologic changes seen in ALS,
such as axonal degeneration and myelin breakdown20 or the
presence of lipid-laden macrophages and an accumulation of
intra-axonal neurofilaments48 may contribute to the T1MTC
shortening.16 Another interesting and intriguing hypothesis is
the presence of toxic metals such as manganese, which is also
known to determine a T1 MTC shortening effect on MR
imaging.49,50
Regarding DTI, the most interesting result of this study is
that there were regional differences in white matter FA be-
tween patients with T1MTChyperintense signal intensity and
patients without it. Patients with T1 MTC abnormal signal
intensity showed lower FA strictly limited to the motor net-
work and the posterior aspect of the body of the CC without
extramotor FA reductions, whereas patients without this sign
showed FA reductions in several confluent regions within and
outside the CST (frontal, temporal, parietal lobes) and in the
whole CC.
Furthermore, we focused on the different clusters of FA
Fig 1. T1 MTC MR sagittal (A and B) and axial (C) images show a hyperintense signal intensity along the CST and in the posterior aspect of the CC (B).
Table 2: Mean FA of clusters with statistically significant differences between patients with ALS with T1 MTC hyperintense signal and those
without it and controlsa
Patients with ALS
ControlsMT Hyperintensity No MT Hyperintensity
Entire CST 0.403 (0.024) 0.432 (0.022) 0.454 (0.024)
CST including internal capsule 0.373 (0.024) 0.411 (0.021) 0.431 (0.024)
Middle cerebellar peduncles 0.435 (0.020) 0.464 (0.019) 0.480 (0.020)
Pons 0.414 (0.014) 0.427 (0.014) 0.445 (0.015)
Entire CC 0.580 (0.018) 0.569 (0.018) 0.619 (0.019)
Genu CC 0.517 (0.022) 0.499 (0.022) 0.549 (0.023)
Body CC 0.530 (0.014) 0.524 (0.014) 0.584 (0.015)
Anterior body CC 0.532 (0.013) 0.514 (0.013) 0.571 (0.014)
Posterior body CC 0.528 (0.015) 0.536 (0.015) 0.602 (0.016)
Splenium CC 0.679 (0.015) 0.665 (0.015) 0.706 (0.015)
Temporal white matter 0.268 (0.013) 0.245 (0.012) 0.281 (0.013)
Parietal white matter 0.236 (0.016) 0.212 (0.015) 0.255 (0.016)
Frontal white matter 0.243 (0.014) 0.234 (0.013) 0.259 (0.014)
a All P values .05. Numbers in parentheses are SDs.
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reductions detected between those patients with T1MTChigh
signal intensity and those without it. In particular, trying to
better understand the T1 MTC signal intensity abnormalities
in the posterior aspect of the body of the CC, we demonstrated
a significant FA decrease in this specific segment of the CC
(with a sparing of the remaining CC segments, thus suggesting
a more severe, focal, interhemispheric fiber damage) in those
patients with T1MTC hyperintense signal intensity compared
with those without it. On the other hand, those patients with-
out T1 MT hyperintense signal intensity showed widespread
FA reductions in the entire CC, not restricted to the posterior
aspect compared with controls.
Reductions of FA in the CC have been described in other
studies in ALS, though the extent and distribution of these
changes have been variable.28,40,51 In a recent TBSS analysis of
patients with ALS, reductions in FA in the splenium and body
of the CC in addition to the previously reported reductions in
FA in the CST have been reported,38 and a reduction in FA in
the CC of the ALS group, extending rostrally and bilaterally
to the region of the primary motor cortices, independent of
the degree of clinical UMN involvement, has been also
described.52
The isthmus of the CC is frequently involved in ALS and in
other conditions such as adult-onset Krabbe disease53; this
region harbors interhemispheric fibers connecting the 2 mo-
tor cortices and is occupied by the motor inhibitory path-
ways.54 Thus, such transcallosal fiber damage might imply a
loss of motor inhibition and explains the clinical finding of
Fig 2. Blue voxels show the regions within and outside the CST, where the FA is significantly reduced in patients with ALS with T1 MTC hyperintense signal intensity compared with patients
with ALS without T1 MTC hyperintense signal intensity (all P values  .05, corrected at the cluster level). Red voxels show the regions where the FA is significantly increased in patients
with ALS with T1 MTC hyperintense signal intensity compared with patients with ALS without T1 MTC hyperintense signal intensity (all P values  .05, corrected at cluster level). In the
CC, patients with T1 MTC hyperintense signal intensity compared with patients without T1 MTC hyperintensity show a significantly lower FA only in the posterior aspect of the body of
the CC, whereas they show higher FA in the entire CC, in the splenium, in the genu, and in the anterior body.
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increased involuntary contralateral co-movements in patients
with ALS.51,55,56
In our 16 patients with the T1 MTC hyperintense signal
intensity in the posterior body of the CC, we demonstrated
significantly lower FA compared with controls and with pa-
tientswithALSwithoutT1MTChyperintense signal intensity,
suggesting more severe interhemispheric fiber damage.
A previous ALS study using TBSS concluded that central
CC FA reductions observed were able to discriminate PLS
from ALS.37 DTI studies of patients with hereditary spastic
paraparesis have also demonstrated prominent posterior CC
involvement, notably not detected in the LMN-only slowly
progressive disorder (ie, X-linked spinobulbar muscular atro-
phy).57 It has been reported that in ALS and PLS, there is a loss
or shrinkage of Betz cells in the premotor cortex, but the cor-
tical motor neurons seem to degenerate more in PLS than
ALS.58 Therefore, all these findings together support the hy-
pothesis that the T1 MTC hyperintense signal intensity, when
present, expresses a distinct ALS phenotype characterized by a
more severe cortical motor neuron degeneration, with a more
prominent “dying back” degeneration of neurons of the CST.
Furthermore, in this subgroup of patients, the degeneration of
collaterals of the CST at the level of corticocortical motor in-
terhemispheric fibers is more pronounced, confirmed by
lower FA in the posterior aspect of the body of the CC com-
pared with patients with ALS without the T1 MTC signal in-
tensity. The fact that in patientswithout T1MTChyperintense
signal intensity the FA reductionswere spread throughout sev-
eral extramotor white matter tracts and the entire CC, con-
firms what some authors have proposed, that the CCmight be
a “conduit” for the pathologic diffusion of the disease to the
frontal areas, explaining cognitive dysfunction present in
some patients with ALS.52
The major limitations in this study are related to the DTI
approach: Though TBSS for analysis of DTI data holds several
advantages, it may not suffice to circumvent systematic errors
such as partial volume effects, especially in very thin structures
such as the fornix and external capsule. Although by using
TBSS, we sampled diffusivity values from the centers of the
tracts, some voxels located on the white matter skeleton were
within the crossings of different fiber pathways. In these vox-
els, FA cannot serve as a marker of myelin and axon integrity,
and the patterns should be interpreted with caution.
Further investigation is necessary to explore the differences
between this group and other patients with ALSwith extramo-
tor FA reduction, by correlating the MTC findings with clini-
cal, neuropsychological, MR spectroscopy, and pathologic
findings. The data must be replicated.
Conclusions
The T1 MTC hyperintense signal intensity in the CST and
posterior body of the CC, when present, is specific for ALS and
represents, among patients with ALS, a possible distinct phe-
notype of presentation of the disease very similar to that in
UMNdisorders, such as PLS, being characterized by FA reduc-
tion strictly in the motor network and in the posterior aspect
of the body of CC, without extramotor FA reductions demon-
strated in patients without this sign. We believe that this se-
quence should be included in the diagnostic work-up of pa-
tients with ALS.
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